SET/TAF-I Antikörper (AbBy Fluor® 555)
Kurzübersicht für SET/TAF-I Antikörper (AbBy Fluor® 555) (ABIN915029)
Target
Alle SET/TAF-I (SET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SET
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: 1:20-100, IF(IHC-P): 1:50-200
Optimal working dilution should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Andere Bezeichnung
- Set
-
Hintergrund
- Optional[synonyms]: SET_HUMAN, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase (IGAAD), PHAPII, Phosphatase 2A inhibitor I2PP2A (I-2PP2A), Template-activating factor I (TAF-I), 2PP2A, IGAAD, MRD58, TAF-I, I2PP2A, IPP2A2, PHAPII, TAF-IBETA,
-
Gen-ID
- 6418
-
UniProt
- Q01105
-
Pathways
- Apoptose
Target
-